申请人:Fujisawa Pharmaceutical Co. Ltd.
公开号:US20040067955A1
公开(公告)日:2004-04-08
A pyridazinone or pyridone compound of the following formula (I).
1
wherein
X is
2
Y is N or CH
or a salt thereof.
The pyridazinone or pyridone compound (I) and a salt thereof of the present invention are adenosine antagonists and are useful for the prevention and/or treatment of depression, dementia (e.g. Alzheimer's disease, cerebrovascular dementia, dementia accompanying Parkinson's disease, etc.), Parkinson's disease, anxiety, pain, cerebrovascular disease (e.g. stroke, etc.), heart failure and the like.
以下是化学式(I)的吡啶并嗪酮或吡啶酮化合物:
其中,X为2,Y为N或CH,或其盐。
本发明的吡啶并嗪酮或吡啶酮化合物(I)及其盐是腺苷拮抗剂,可用于预防和/或治疗抑郁症、痴呆症(例如阿尔茨海默病、脑血管性痴呆、帕金森病相关的痴呆等)、帕金森病、焦虑症、疼痛、脑血管疾病(例如中风等)、心力衰竭等。